
PF-07258669
CAS No. 2755890-53-8
PF-07258669( —— )
Catalog No. M36282 CAS No. 2755890-53-8
PF-07258669 is a selective melanocortin 4 receptor (MC4) antagonist used in the study of cachexia and loss of appetite.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 1284 | Get Quote |
![]() ![]() |
5MG | 1606 | Get Quote |
![]() ![]() |
10MG | 2613 | Get Quote |
![]() ![]() |
25MG | 4996 | Get Quote |
![]() ![]() |
50MG | 7995 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePF-07258669
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-07258669 is a selective melanocortin 4 receptor (MC4) antagonist used in the study of cachexia and loss of appetite.
-
DescriptionPF-07258669 is a melanocortin-4 receptor (MC4) antagonist. PF-07258669 can be used for the research of cachexia, anorexia, or anorexia nervosa.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetMelanocortin Receptor
-
RecptorMelanocortin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2755890-53-8
-
Formula Weight462.52
-
Molecular FormulaC25H27FN6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC([C@H](C)C=1C=C(OC)N=CC1F)(=O)N2C[C@@]3(NC=4C(CC3)=CC(=C(C)N4)C=5N=CC=CN5)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Christopher Ryan BUTLER, et al. Spiro compounds as melanocortin 4 receptor antagonists and uses thereof. Patent. WO2021250541A1.
molnova catalog



related products
-
AP1189 acetate
AP1189 acetate is a biased agonist at melanocortin 1 and melanocortin 3 receptors.
-
Dersimelagon
Dersimelagon (MT-7117) is an orally active, selective melanocortin 1 receptor (MC1R) agonist with EC50 values ??of 8.16, 3.91, 1.14, and 0.251 nM for human (h), cynomolgus monkey (cm), mouse (m), and rat (r) MC1R, respectively.
-
PG 931
Potent and selective melanocortin 4 (MC4) receptor agonist (IC50 values are 0.58 and 55 nM for human MC4 and MC3 receptors respectively). Produces a rapid and dose dependent restoration of cardiovascular and respiratory function in hemorrhage-shocked rats.